Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinical features of SSc patients involved in monocyte experiments

From: Differential regulation of cell functions by CSD peptide subdomains

Race/Smoking Gender Patients Controls
Caucasian M 2 9
Caucasian F 7 12
African-American M 3 2
African-American F 3 9
Asian F 0 1
Smoker   0 2
Former Smoker   2 3
Age: Mean ± SD (range) Patients 52.3 ± 12.8 (27–79)
  Controls 43.0 ± 11.9 (18–64)
Disease Limited Cutaneous 3
  Diffuse Cutaneous 9
  Overlap 3
Disease duration: Mean ± SD (range), yr 4.3 ± 2.8 (1-10)
Pulmonary Involvement (ILD)   15/15 (100%)
Pulmonary HTN   3/15 (20%)
GI Involvement   15/15 (100%)
Cardiac Involvement   2/15 (13.3%)
Renal Involvement   1/15 (6.7%)
Autoantibodies: ANA+ 15/15 (100%)
  Scl-70+ 6/15 (40%)
  Anti-centromere 1/15 (6.7%)